a16z Capital Management, L.L.C.

Position in ERAS — Erasca, Inc.

CIK 1540358 MENLO PARK, CA

Position in ERAS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$52,441,000

+$6,125,750 QoQ

Shares Held

2,862,500

0.0% QoQ

Ownership

0.818%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#21

of 255 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

a16z Capital Management, L.L.C. holds $351,662,456 across 9 Biotechnology names. ERAS ranks #2 (14.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	921,099	$172,503,420
2	ERAS	Erasca, Inc. This page	2,862,500	$52,441,000
3	MAZE	Maze Therapeutics, Inc.	1,702,225	$50,794,394
4	DMRA	Damora Therapeutics, Inc.	1,236,157	$32,152,443
5	NAUT	Nautilus Biotechnology, Inc.	9,063,054	$16,947,910
6	AKTS	Aktis Oncology, Inc.	415,000	$13,375,450
7	CAMP	Camp4 Therapeutics Corp	2,125,339	$9,287,731
8	KLRA	Kailera Therapeutics, Inc.	140,000	$3,084,200

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$52,441,000	2,862,500	0.0%	Shares	Sole	2026-08-14
2026-03-31	$46,315,250	2,862,500	0.0%	Shares	Sole	2026-05-15
2025-12-31	$10,648,500	2,862,500	0.0%	Shares	Sole	2026-02-17
2025-09-30	$6,240,250	2,862,500	0.0%	Shares	Sole	2025-11-14
2025-06-30	$3,635,375	2,862,500	0.0%	Shares	Sole	2025-08-14
2025-03-31	$3,921,625	2,862,500	0.0%	Shares	Sole	2025-05-15
2024-12-31	$7,184,875	2,862,500	0.0%	Shares	Sole	2025-02-12
2024-09-30	$7,814,625	2,862,500	0.0%	Shares	Sole	2024-11-13
2024-06-30	$6,755,500	2,862,500	0.0%	Shares	Sole	2024-08-13
2024-03-31	$5,896,750	2,862,500	0.0%	Shares	Sole	2024-05-15
2023-12-31	$6,097,125	2,862,500	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.